The Food and Drug Law Institute (FDLI) will present academic scholarship at the 2022 Food and Drug Law Journal Symposium exploring the relationships between FDA and other domestic regulators. This Symposium will offer wide-ranging discussion, among scholars and practitioners, of the actual and the possible, the problematic and the productive, what has been learned, what should be studied, what might be changed, practical impediments and legal obstacles, cautions and concerns, and what the future might hold.
The Food and Drug Law Journal Symposium will encourage thoughtful legal scholarship on topics that may be historical, descriptive, empirical, theoretical, or normative, as the subject dictates. Papers to be presented will consider domestic regulators, or combination of them, from the CDC, CMS, and other sister agencies within HHS, to the Patent and Trademark Office (PTO), FTC, DoD, SEC, EPA, and state regulators.
For a full list of topics, please visit our agenda webpage here.